DrugPatentWatch Database Preview
Drugs in Development Information for Putrescine
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for Putrescine?
Putrescine is an investigational drug.
There have been 6 clinical trials for Putrescine.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Subarachnoid Hemorrhage, and Hemorrhage. The leading clinical trial sponsors are National Cancer Institute (NCI), Ministry of Health, France, and BioGaia AB.
There are three US patents protecting this investigational drug and twenty-seven international patents.
Summary for Putrescine
| US Patents | 3,152 |
| International Patents | 27,911 |
| US Patent Applications | 3,742 |
| WIPO Patent Applications | 2,234 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 62 |
Recent Clinical Trials for Putrescine
| Title | Sponsor | Phase |
|---|---|---|
| Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis | BioGaia AB | Phase 4 |
| Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis | University of Zagreb | Phase 4 |
| Feasibility Study on Stem Cells Sensitivity Assay | Associazione Oncologia Traslazionale | Phase 2 |
Clinical Trial Summary for Putrescine
Top disease conditions for Putrescine
Top clinical trial sponsors for Putrescine
US Patents for Putrescine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Putrescine | Start Trial | Method of molding plastic products having chemically bonded protective coatings | Libbey-Owens-Ford Co. (Toledo, OH) | Start Trial |
| Putrescine | Start Trial | Epoxy adhesive for bonding of automotive parts made from bulk or sheet molding compound containing polymeric toughening agent and Mannich Base | American Cyanamid (CT) | Start Trial |
| Putrescine | Start Trial | Aryloxytriazine-capped polyphenylene ethers and method for their preparation | General Electric Company (Schenectady, NY) | Start Trial |
| Putrescine | Start Trial | Method for producing polyurethanes from poly-(hydroxyalkyl urethanes) | Medtronic, Inc. (Minneapolis, MN) | Start Trial |
| Putrescine | Start Trial | Foam regulators suitable for use in detergents and cleaning preparations | Henkel Kommanditgesellschaft auf Aktien (Duesseldorf, DE) | Start Trial |
| Putrescine | Start Trial | Cell culture microcarriers | Mitsubishi Kasei Corporation (Tokyo, JP) | Start Trial |
| Putrescine | Start Trial | Internal mold release compositions | The Dow Chemical Company (Midland, MI) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Putrescine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Putrescine | Australia | 5432390 | 2009-04-06 | Start Trial |
| Putrescine | Australia | 630691 | 2009-04-06 | Start Trial |
| Putrescine | Brazil | 9006288 | 2009-04-06 | Start Trial |
| Putrescine | Canada | 2013696 | 2009-04-06 | Start Trial |
| Putrescine | European Patent Office | 0418373 | 2009-04-06 | Start Trial |
| Putrescine | Japan | H03505312 | 2009-04-06 | Start Trial |
| Putrescine | Mexico | 173313 | 2009-04-06 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
